icer white paper affordable access to glp-1 obesity medications 2025 Weight Loss Treatment Dynamic GLP GLP-1 therapy for weight loss

Elevated medium-chain acylcarnitines in this group mirrored those seen in the TB cohort, hinting at increased fatty acid oxidation possibly linked to dysfunctional mitochondrial respiration often associated with diabetes

Drugs like semaglutide (Ozempic, Rybelsus, Wegovy) and liraglutide (Victoza) have reshaped how we treat obesity and protect the cardiovascular system

They're designed to work best when you're already making an effort to eat well and move your body

Weekly semaglutide injections are the more traditional and evidence-supported route for GLP-1 weight management

Across the telehealth weight-loss market as of April 2026, monthly totals commonly fall between roughly $200 and $700 or more depending on the medication and tier